# US 2008/0305175 A1 · Micro-Container

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305175 A1
- Document ID: US20080305175A1
- Status: Published application
- Kind: A1
- Application number: 11/947,522
- Filed: 2007-11-29
- Published: 2008-12-11
- Earliest claimed: 2006-11-30
- Assignees: Agency for Science, Technology and Research
- Inventors: Yubo Wang; Wei Zheng; Mingyong Han; Kaiyu Wang
- Web page: https://patentgrep.com/patent/US20080305175A1

## CPC

- A61K 9/5026: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/5089: {Processes}
- A61K 31/704: attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

There is disclosed a method of making a micro-container. The method comprises the step of evaporating a swelling agent solution absorbed in a polymer micro-particle to form an inner void therein. The evaporating step is undertaken under conditions to form a conduit extending through the shell wall of said micro-particle and into the inner void.

## Claims

### Claim 1

A method of making a micro-container comprising the step of evaporating a swelling agent solution absorbed in a polymer micro-particle to form an inner void therein, wherein said evaporating is undertaken under conditions to form a conduit extending through the shell wall of said micro-particle and into the inner void.

### Claim 2 (depends on 1)

The method of claim 1, wherein said micro-particle is a microsphere.

### Claim 3 (depends on 1)

The method of claim 1, comprising the step of selecting an organic liquid as said swelling agent solution.

### Claim 4 (depends on 3)

The method of claim 3, wherein the organic liquid is a non-polar hydrocarbon liquid.

### Claim 5 (depends on 4)

The method of claim 4, wherein the non-polar hydrocarbon liquid is selected from the group consisting of n-pentane, n-hexane, n-heptane and n-octane.

### Claim 6 (depends on 1)

The method of claim 1, wherein the evaporating step is undertaken at a temperature less than the boiling point of the swelling agent solution, or at a temperature less than 15° C. of the boiling point of the swelling agent solution, or at a temperature less than 10° C. of the boiling point of the swelling agent solution.

### Claim 7 (depends on 1)

The method of claim 1, wherein the evaporating step comprises the step of polymerizing a monomeric mixture in droplet form in the presence of the swelling agent solution to form the micro-particle in the form of a polymer microsphere having the swelling agent solution absorbed therein.

### Claim 8 (depends on 1)

The method of claim 1, comprising the step of hardening the outer shell wall.

### Claim 9 (depends on 8)

The method of claim 8, wherein the hardening step comprises the step of providing a cross-linking agent within said monomeric mixture.

### Claim 10 (depends on 7)

The method of claim 7, wherein the polymerizing step comprises the step of providing seed particles within the swelling agent solution.

### Claim 11 (depends on 10)

The method of claim 10, wherein the seed particles are comprised of a polymer that is substantially non-polar.

### Claim 12 (depends on 7)

The method of claim 7, wherein the monomeric mixture is in the form of an emulsion of monomers.

### Claim 13 (depends on 7)

The method of claim 7, wherein the monomeric mixture includes polymer seed particles, a cross-linking agent, a stabilizer and an organic solvent.

### Claim 14 (depends on 10)

The method of claim 10, wherein the seed particles are provided in a monodispersion form.

### Claim 15 (depends on 7)

The method of claim 7, wherein the polymerizing step comprises the step of providing a solvent that is immiscible with said swelling agent solution.

### Claim 16 (depends on 10)

The method of claim 10, wherein the volume ratio of swelling agent solution to the mass of seed particles is lower than about 3 ml/mg.

### Claim 17 (depends on 1)

The method of claim 1, comprising the step of loading said inner void with a substance.

### Claim 18 (depends on 17)

The method of claim 17, wherein the substance is selected from the group consisting of inks, dyes, drugs, quantum dots and catalysts.

### Claim 19 (depends on 17)

The method of claim 17, wherein the loading step comprises loading said inner void with a drug dissolved in a solvent.

### Claim 20 (depends on 19)

The method of claim 19, comprising the step of evaporating the solvent to form drug particles in said void.

### Claim 21

A micro-container comprising a polymer micro-particle having an inner void and a conduit extending through the shell wall of the micro-particle to said inner void.

### Claim 22 (depends on 23)

The micro-container of claim 23, wherein said micro-particle is in the form of a microsphere.

### Claim 23 (depends on 21)

The micro-container of claim 21, wherein the diameter of the micro-particle is in the range of 1 μm to 5 μm.

### Claim 24 (depends on 21)

The micro-container of claim 21, wherein the diameter of the inner void is in the range of 0.1 μm to 4.9 μm.

### Claim 25 (depends on 21)

The micro-container of claim 21, wherein the average thickness of the shell wall is less than about 2 μm.

### Claim 26 (depends on 21)

The micro-container of claim 21, wherein the average diameter of the conduit is in the range of 50 nm to 500 nm.

### Claim 27 (depends on 21)

The micro-container of claim 21, wherein the outer surface of the micro-particle is chemically modified by a functional group.

### Claim 28 (depends on 27)

The micro-container of claim 27, wherein the functional group is carboxylate.

### Claim 29 (depends on 21)

The micro-container of claim 21, wherein the micro-particle is biodegradable.

### Claim 30 (depends on 21)

The micro-container of claim 21, wherein the shell wall is selectively permeable.
